211 related articles for article (PubMed ID: 17507307)
1. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts.
Kienle GS; Kiene H
Eur J Med Res; 2007 Mar; 12(3):103-19. PubMed ID: 17507307
[TBL] [Abstract][Full Text] [Related]
2. Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research.
Kienle GS; Glockmann A; Schink M; Kiene H
J Exp Clin Cancer Res; 2009 Jun; 28(1):79. PubMed ID: 19519890
[TBL] [Abstract][Full Text] [Related]
3. Mistletoe in cancer - a systematic review on controlled clinical trials.
Kienle GS; Berrino F; Büssing A; Portalupi E; Rosenzweig S; Kiene H
Eur J Med Res; 2003 Mar; 8(3):109-19. PubMed ID: 12730032
[TBL] [Abstract][Full Text] [Related]
4. Mistletoe therapy in oncology.
Horneber MA; Bueschel G; Huber R; Linde K; Rostock M
Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD003297. PubMed ID: 18425885
[TBL] [Abstract][Full Text] [Related]
5. Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies.
Kienle GS; Kiene H
Integr Cancer Ther; 2010 Jun; 9(2):142-57. PubMed ID: 20483874
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review.
Melzer J; Iten F; Hostanska K; Saller R
Forsch Komplementmed; 2009 Aug; 16(4):217-26. PubMed ID: 19729932
[TBL] [Abstract][Full Text] [Related]
7. Randomized and double-blind studies--demands and reality as demonstrated by two examples of mistletoe research.
Rostock M; Huber R
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():18-22. PubMed ID: 15353898
[TBL] [Abstract][Full Text] [Related]
8. Mistletoe for cancer? A systematic review of randomised clinical trials.
Ernst E; Schmidt K; Steuer-Vogt MK
Int J Cancer; 2003 Nov; 107(2):262-7. PubMed ID: 12949804
[TBL] [Abstract][Full Text] [Related]
9. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
10. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
Pelzer F; Tröger W; Nat DR
J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
[TBL] [Abstract][Full Text] [Related]
11. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.
Grossarth-Maticek R; Ziegler R
Eur J Med Res; 2006 Nov; 11(11):485-95. PubMed ID: 17182361
[TBL] [Abstract][Full Text] [Related]
12. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R; Ziegler R
Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
[TBL] [Abstract][Full Text] [Related]
13. [Clinical research on anthroposophic medicine:update of a health technology assessment report and status quo].
Kienle GS; Glockmann A; Grugel R; Hamre HJ; Kiene H
Forsch Komplementmed; 2011; 18(5):269-82. PubMed ID: 22105040
[TBL] [Abstract][Full Text] [Related]
14. [Anthroposophic medicine: health technology assessment report - short version].
Kienle GS; Kiene H; Albonico HU
Forsch Komplementmed; 2006; 13 Suppl 2():7-18. PubMed ID: 16883076
[TBL] [Abstract][Full Text] [Related]
15. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
[TBL] [Abstract][Full Text] [Related]
16. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial.
Piao BK; Wang YX; Xie GR; Mansmann U; Matthes H; Beuth J; Lin HS
Anticancer Res; 2004; 24(1):303-9. PubMed ID: 15015612
[TBL] [Abstract][Full Text] [Related]
17. Systematic evaluation of the clinical effects of supportive mistletoe treatment within chemo- and/or radiotherapy protocols and long-term mistletoe application in nonmetastatic colorectal carcinoma: multicenter, controlled, observational cohort study.
Friedel WE; Matthes H; Bock PR; Zänker KS
J Soc Integr Oncol; 2009; 7(4):137-45. PubMed ID: 19883529
[TBL] [Abstract][Full Text] [Related]
18. Mistletoe treatments for minimising side effects of anticancer chemotherapy.
Lange-Lindberg AM; Velasco Garrido M; Busse R
GMS Health Technol Assess; 2006 Sep; 2():Doc18. PubMed ID: 21289969
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in cancer patients treated with mistletoe: a systematic review and meta-analysis.
Loef M; Walach H
BMC Complement Med Ther; 2020 Jul; 20(1):227. PubMed ID: 32690087
[TBL] [Abstract][Full Text] [Related]
20. Mistletoe and cancer: controversies and perspectives.
Mansky PJ
Semin Oncol; 2002 Dec; 29(6):589-94. PubMed ID: 12516042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
